levofloxacin has been researched along with pyrazines in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (pyrazines) | Trials (pyrazines) | Recent Studies (post-2010) (pyrazines) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 12,165 | 1,373 | 5,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JS; Jang, HC; Jung, SH; Kang, SJ; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH | 1 |
| Biava, G; Chinello, P; Ippolito, G; Nicastri, E; Petrosillo, N; Pittalis, S | 1 |
2 other study(ies) available for levofloxacin and pyrazines
| Article | Year |
|---|---|
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Comorbidity; Female; Humans; Incidence; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome | 2014 |
QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
Topics: Adult; Amides; Antiviral Agents; Arrhythmias, Cardiac; Ebolavirus; Electrocardiography; Hemorrhagic Fever, Ebola; Humans; Italy; Levofloxacin; Male; Pyrazines; RNA-Dependent RNA Polymerase; Virus Replication | 2017 |